Through the three selected strategies as well as combining the GBM correlation analysis with survival analysis and AI-proposed GBM targets, we identified three potential therapeutic targets: CNGA3, GLUD1, and SIRT1, which we propose to investigate in further studies. The gene discussed is CNGA3; the disease is glioblastoma.